Clinical Trials · NCT01001104
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 145
- Start date
- Oct 2009
- Locations
- 6 sites, Japan
- Primary endpoint
- Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 12 Weeks